Guiyang Xintian Pharmaceutical(002873.SZ): Xinkang Capsules approved to conduct clinical trials for the treatment of cancer-related fatigue.
Xintian Pharmaceutical (002873.SZ) announcement, the company recently received the approval of Xinli Kang Gel issued by the National Medical Products Administration...
Guiyang Xintian Pharmaceutical (002873.SZ) announced that the company recently received the approval notice for clinical trial of Xinkang Capsules issued by the National Medical Products Administration. The approval allows the company to conduct clinical trials for the treatment of cancer-related fatigue with Xinkang Capsules.
Related Articles
GF SEC (01776) issued 3 billion yuan worth of short-term corporate bonds.
BOSIDENG (03998) issued a total of 2.78 million shares due to its purchase of stock options.
Nanjing CIGU Technology Corp., LTD. (688448.SH) shareholder Xu Longxiang intends to reduce his shareholding by no more than 0.86%.
GF SEC (01776) issued 3 billion yuan worth of short-term corporate bonds.
BOSIDENG (03998) issued a total of 2.78 million shares due to its purchase of stock options.
Nanjing CIGU Technology Corp., LTD. (688448.SH) shareholder Xu Longxiang intends to reduce his shareholding by no more than 0.86%.
RECOMMEND
